免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Solaris 注射器用 MR 注射器双包装

K号: K161471 · 2016-10-06

申请人Coeur, Inc.
决定日期2016-10-06
产品代码DXT
咨询委员会CV 请注意,由于原文未提供具体内容,以下是一个示例翻译: --- 产品名称:[产品名称] 公司名称:[公司名称] FDA批准号:[FDA批准号] 510(k)申请号:[510(k)申请号] PMA申请号:[PMA申请号] 临床试验注册号:[NCT] PubMed ID:[PMID] 产品标识符:[标识符] 产品URL:[URL] --- 请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。
决定实质等同

器械摘要

MR Syringe Dual Pack for Solaris Injectors is the device name listed in this FDA 510(k) record. The listed applicant is Coeur, Inc.. It received FDA 510(k) clearance on 2016-10-06 under 510(k) number K161471. The device is classified under product code DXT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the MR Syringe Dual Pack for Solaris Injectors?

MR Syringe Dual Pack for Solaris Injectors is a medical device that received FDA 510(k) clearance on 2016-10-06. The listed applicant is Coeur, Inc.. The 510(k) number is K161471.

When did MR Syringe Dual Pack for Solaris Injectors receive FDA 510(k) clearance?

MR Syringe Dual Pack for Solaris Injectors received FDA 510(k) clearance on 2016-10-06, under 510(k) number K161471.

Who is the listed applicant for MR Syringe Dual Pack for Solaris Injectors?

The FDA 510(k) record lists Coeur, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MR Syringe Dual Pack for Solaris Injectors?

The FDA product code for MR Syringe Dual Pack for Solaris Injectors is DXT.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Coeur, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:DXT)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑